iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Kronox Lab Sciences Files for IPO with SEBI

19 Apr 2024 , 08:59 AM

Speciality chemicals manufacturer Kronox Lab Sciences has filed draft papers for an initial public offering (IPO) with plans to raise around Rs 150 crore. The IPO is a pure OFS of 96 lakh equity shares by promoters.

The selling shareholders are promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani. The company is currently 100% owned by these promoters, with Jaswal and Ketan Ramani each holding a 34.99% stake, and Pritesh Ramani holding 30%. The remaining shares are held by families of Jaswal and Ramani.

Proceeds from the fresh issue will primarily be allocated to working capital requirements, with the remaining set aside for general corporate purposes.

Kronox Lab Sciences, based in Gujarat, produces speciality fine chemicals used in various industries such as pharmaceuticals, biotech, agrochemicals, personal care, metal refineries, and animal health products. The company supplies over 185 products to customers in India and more than 20 countries.

In terms of financials, for the fiscal year ended March FY23, Kronox Lab recorded a 22% YoY growth in net profit at Rs 16.6 crore, and revenue increased by 16.2% to Rs 95.6 crore. EBITDA jumped 11.7% to Rs 22 crore, but the margin dropped to 23.01% due to rising input costs.

As of the quarter ending June FY24, the company reported a net profit of Rs 6.38 crore on revenue of Rs 25.95 crore. Kronox Lab Sciences is a debt-free company.

Pantomath Capital Advisors is the lead manager for the IPO, and KFin Technologies is the registrar.

Kronox Lab Sciences

Related Tags

  • Kronox Lab Sciences
  • Kronox Lab Sciences DRHP
  • Kronox Lab Sciences IPO
  • Kronox Lab Sciences IPO Details
sidebar mobile


Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.


Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp